{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:49:45Z","timestamp":1760215785009},"reference-count":38,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.3892\/mco.2013.175","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T09:55:58Z","timestamp":1378115758000},"page":"942-948","source":"Crossref","is-referenced-by-count":10,"title":["Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma"],"prefix":"10.3892","volume":"1","author":[{"given":"KAZUYA","family":"FUKUOKA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOZO","family":"KURIBAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUSAI","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KUNIHIRO","family":"TAMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHIHARU","family":"TABATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"NAKANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,9,2]]},"reference":[{"key":"key20180107151939_b1-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107151939_b2-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107151939_b3-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107151939_b4-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","article-title":"Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial","volume":"36","author":"Van Schil","year":"2010","journal-title":"Eur Respir J"},{"key":"key20180107151939_b5-mco-01-06-0942","first-page":"2971","article-title":"Cyfra 21-1 and TPA as markers in malignant mesothelioma","volume":"17","author":"Bonfrer","year":"1997","journal-title":"Anticancer Res"},{"key":"key20180107151939_b6-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-5002(99)00044-6","article-title":"Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma","volume":"25","author":"Schouwink","year":"1999","journal-title":"Lung Cancer"},{"key":"key20180107151939_b7-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1378\/chest.119.4.1138","article-title":"Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma","volume":"119","author":"Paganuzzi","year":"2001","journal-title":"Chest"},{"key":"key20180107151939_b8-mco-01-06-0942","first-page":"531","article-title":"Tissue polypeptide antigen (TPA), hyaluronan and CA 125 as serum markers in malignant mesothelioma","volume":"23","author":"Hedman","year":"2003","journal-title":"Anticancer Res"},{"key":"key20180107151939_b9-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1378\/chest.07-0013","article-title":"Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma","volume":"132","author":"Creaney","year":"2007","journal-title":"Chest"},{"key":"key20180107151939_b10-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107151939_b11-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","article-title":"Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment","volume":"13","author":"Grigoriu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107151939_b12-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/JTO.0b013e318180477b","article-title":"Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma","volume":"3","author":"Creaney","year":"2008","journal-title":"J Thorac Oncol"},{"key":"key20180107151939_b13-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/CCLM.2010.066","article-title":"Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels","volume":"48","author":"Rai","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"key20180107151939_b14-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2011.02.007","article-title":"Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma - which is best?","volume":"74","author":"Creaney","year":"2011","journal-title":"Lung Cancer"},{"key":"key20180107151939_b15-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","article-title":"Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma","volume":"6","author":"Cristaudo","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key20180107151939_b16-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107151939_b17-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1378\/chest.08-2665","article-title":"Malignant pleural mesothelioma: an update on biomarkers and treatment","volume":"136","author":"Ray","year":"2009","journal-title":"Chest"},{"key":"key20180107151939_b18-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.200907-1020OC","article-title":"Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma","volume":"181","author":"Hollevoet","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180107151939_b19-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2217\/bmm.11.18","article-title":"Soluble markers for diagnosis of malignant pleural mesothelioma","volume":"5","author":"Cristaudo","year":"2011","journal-title":"Biomark Med"},{"key":"key20180107151939_b20-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","article-title":"Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis","volume":"30","author":"Hollevoet","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107151939_b21-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2011.104","article-title":"Markers for the non-invasive diagnosis of mesothelioma: a systematic review","volume":"104","author":"van der Bij","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180107151939_b22-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1158\/1078-0432.CCR-03-0365","article-title":"Osteopontin as an adjunct to CA125 in determining recurrent ovarian cancer","volume":"10","author":"Schorge","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107151939_b23-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1158\/1055-9965.1640.13.10","article-title":"Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?","volume":"13","author":"Etzioni","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107151939_b24-mco-01-06-0942","volume-title":"World Health Organization Classification of Tumors, Pathology and Genetics. Tumours of the Lung, Pleura, Thymus, and Heart","author":"Travis","year":"2004"},{"key":"key20180107151939_b25-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5858\/133.8.1317","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group","volume":"133","author":"Husain","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"key20180107151939_b26-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristics curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"key20180107151939_b27-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1373\/clinchem.2006.079327","article-title":"Mesomark: a potential test for malignant pleural mesothelioma","volume":"53","author":"Beyer","year":"2007","journal-title":"Clin Chem"},{"key":"key20180107151939_b28-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/CBM-2007-3602","article-title":"Soluble mesothelin-related peptides (SMRP)-high stability of a potential tumor marker for mesothelioma","volume":"3","author":"Weber","year":"2007","journal-title":"Cancer Biomark"},{"key":"key20180107151939_b29-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.200511-1789OC","article-title":"Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma","volume":"173","author":"Scherpereel","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180107151939_b30-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1158\/1078-0432.CCR-07-0629","article-title":"Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer","volume":"13","author":"Cristaudo","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107151939_b31-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-07-0607","article-title":"Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study","volume":"17","author":"Amati","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107151939_b32-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.athoracsur.2007.07.042","article-title":"Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions","volume":"85","author":"Pass","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"key20180107151939_b33-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/JTO.0b013e318187491c","article-title":"Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer","volume":"3","author":"Schneider","year":"2008","journal-title":"J Thorac Oncol"},{"key":"key20180107151939_b34-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.lungcan.2007.08.030","article-title":"Non-invasive diagnosis of pleural malignancies: the role of tumour markers","volume":"59","author":"van den Heuvel","year":"2008","journal-title":"Lung Cancer"},{"key":"key20180107151939_b35-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1055-9965.EPI-08-0422","article-title":"Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure","volume":"18","author":"Rodriguez Portal","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107151939_b36-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"key20180107151939_b37-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00000478-200308000-00001","article-title":"The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma","volume":"27","author":"Ordonez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"key20180107151939_b38-mco-01-06-0942","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ordonez","year":"2003","journal-title":"Am J Surg Pathol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2013.175\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T07:43:44Z","timestamp":1688456624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2013.175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,2]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,9,2]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.3892\/mco.2013.175"],"URL":"https:\/\/doi.org\/10.3892\/mco.2013.175","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,2]]}}}